| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05108946 | 2005-09-28 | ||
| PCT/EP2006/066438WO2007039436A1 (en) | 2005-09-28 | 2006-09-18 | Treatment of neurodegenerative disorders |
| Publication Number | Publication Date |
|---|---|
| DK1940447T3true DK1940447T3 (da) | 2014-01-20 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06793581.7TDK1940447T3 (da) | 2005-09-28 | 2006-09-18 | Behandling af neurodegenrative lidelser |
| Country | Link |
|---|---|
| US (2) | US20070072795A1 (da) |
| EP (1) | EP1940447B1 (da) |
| JP (1) | JP5096345B2 (da) |
| KR (1) | KR20080038440A (da) |
| CN (1) | CN101277715B (da) |
| AR (1) | AR055654A1 (da) |
| AU (1) | AU2006298826B2 (da) |
| BR (1) | BRPI0616572A2 (da) |
| CA (1) | CA2622609A1 (da) |
| DK (1) | DK1940447T3 (da) |
| ES (1) | ES2445035T3 (da) |
| IL (1) | IL189853A (da) |
| PL (1) | PL1940447T3 (da) |
| RU (1) | RU2467761C2 (da) |
| SI (1) | SI1940447T1 (da) |
| TW (1) | TWI380824B (da) |
| WO (1) | WO2007039436A1 (da) |
| ZA (1) | ZA200802270B (da) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR067536A1 (es) | 2007-07-17 | 2009-10-14 | Hoffmann La Roche | Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea |
| CL2008002053A1 (es) | 2007-07-17 | 2009-05-22 | Hoffmann La Roche | Metodo para la purificacion de una eritropoyetina monopeguilada (epompeg) que consiste en proporcionar una solucion que contiene eritropoyetina mono, poli y no peguilada y hacerla pasar por dos pasos de cromatografia de intercambio cationico y metodo para producir epo mpeg que incluye metodo de purificacion. |
| RU2515914C1 (ru)* | 2013-02-12 | 2014-05-20 | Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт генетики и селекции промышленных микроорганизмов" (ФГУП "ГосНИИгенетика" | Гибридный белок на основе рекомбинантного эритропоэтина человека, обладающий пролонгированным действием (варианты), и способ его получения |
| RU2561050C2 (ru) | 2013-08-28 | 2015-08-20 | Федеральное государственное бюджетное учреждение науки Институт биофизики клетки Российской академии наук (ИБК РАН) | Применение белка yb-1 и его фрагментов для изготовления лекарственных средств при лечении болезни альцгеймера |
| AR113091A1 (es)* | 2018-09-27 | 2020-01-22 | Univ Nacional Del Litoral | Eritropoyetina humana modificada |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US644077A (en)* | 1898-08-01 | 1900-02-27 | Farbenfabriken Of Elberfeld Company | Acetyl salicylic acid. |
| FR2646438B1 (fr)* | 1989-03-20 | 2007-11-02 | Pasteur Institut | Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration |
| US5641670A (en)* | 1991-11-05 | 1997-06-24 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
| US5733761A (en)* | 1991-11-05 | 1998-03-31 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
| US5672662A (en)* | 1995-07-07 | 1997-09-30 | Shearwater Polymers, Inc. | Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications |
| US6703381B1 (en)* | 1998-08-14 | 2004-03-09 | Nobex Corporation | Methods for delivery therapeutic compounds across the blood-brain barrier |
| HUP0201598A3 (en)* | 1999-04-13 | 2002-10-28 | Kenneth S Warren Inst Ossining | Pharmaceutical composition comprising erythropoietin for modulation of excitable tissue function and their use |
| US6225895B1 (en)* | 1999-05-26 | 2001-05-01 | Floyd E. Bigelow, Jr. | Towed vehicle monitor system |
| CZ299516B6 (cs)* | 1999-07-02 | 2008-08-20 | F. Hoffmann-La Roche Ag | Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem |
| DE60109625T3 (de)* | 2000-05-15 | 2017-08-03 | F. Hoffmann-La Roche Ag | Flüssige arzneizubereitung enthaltend ein erythropoietin derivat |
| WO2002003848A2 (en)* | 2000-07-10 | 2002-01-17 | Naito Albert T | Method for opening the blood-brain barrier |
| DE10043457A1 (de)* | 2000-09-04 | 2002-03-28 | Hannelore Ehrenreich | Verfahren zur Behandlung von Schizophrenie und verwandten Psychosen sowie Verwendung von Erythropoietin oder Erythropoietinderivaten zur Behandlung von Schizophrenien und verwandten Psychosen |
| EP1345628B1 (en)* | 2000-12-20 | 2011-04-13 | F. Hoffmann-La Roche AG | Conjugates of erythropoietin (epo) with polyethylene glycol (peg) |
| US6531121B2 (en)* | 2000-12-29 | 2003-03-11 | The Kenneth S. Warren Institute, Inc. | Protection and enhancement of erythropoietin-responsive cells, tissues and organs |
| US7767643B2 (en)* | 2000-12-29 | 2010-08-03 | The Kenneth S. Warren Institute, Inc. | Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| US20030072737A1 (en)* | 2000-12-29 | 2003-04-17 | Michael Brines | Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
| AU2003273615B2 (en)* | 2002-06-11 | 2010-07-29 | Brigham And Women's Hospital | Neuroprotective synergy of erythropoietin and insulin-like growth factor |
| US20040122216A1 (en)* | 2002-07-01 | 2004-06-24 | Jacob Nielsen | Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs |
| US7459436B2 (en)* | 2002-11-22 | 2008-12-02 | Hoffmann-La Roche Inc. | Treatment of disturbances of iron distribution |
| US7718363B2 (en)* | 2003-04-25 | 2010-05-18 | The Kenneth S. Warren Institute, Inc. | Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds |
| CA2526096A1 (en)* | 2003-05-19 | 2004-12-29 | The Kenneth S. Warren Institute, Inc. | Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window |
| DK1696947T3 (da)* | 2003-12-19 | 2014-03-17 | Hoffmann La Roche | Anvendelse af erythropoietin i behandlingen af forstyrrelser af jernfordelingen i kronisk inflammatorisk intestinale sygdomme |
| DE602006018334D1 (de)* | 2005-09-28 | 2010-12-30 | Hoffmann La Roche | Indol-3-ylcarbonylazaspiroderivate als vasopressinrezeptorantagonisten |
| Publication number | Publication date |
|---|---|
| EP1940447A1 (en) | 2008-07-09 |
| CN101277715A (zh) | 2008-10-01 |
| CA2622609A1 (en) | 2007-04-12 |
| ZA200802270B (en) | 2009-02-25 |
| TWI380824B (zh) | 2013-01-01 |
| PL1940447T3 (pl) | 2014-04-30 |
| BRPI0616572A2 (pt) | 2009-11-24 |
| AR055654A1 (es) | 2007-08-29 |
| WO2007039436A1 (en) | 2007-04-12 |
| AU2006298826A1 (en) | 2007-04-12 |
| JP5096345B2 (ja) | 2012-12-12 |
| US20100267632A1 (en) | 2010-10-21 |
| RU2008116309A (ru) | 2009-11-10 |
| IL189853A (en) | 2012-06-28 |
| KR20080038440A (ko) | 2008-05-06 |
| RU2467761C2 (ru) | 2012-11-27 |
| AU2006298826B2 (en) | 2010-04-01 |
| SI1940447T1 (sl) | 2014-03-31 |
| US20070072795A1 (en) | 2007-03-29 |
| EP1940447B1 (en) | 2013-11-27 |
| IL189853A0 (en) | 2008-11-03 |
| JP2009510008A (ja) | 2009-03-12 |
| CN101277715B (zh) | 2013-03-27 |
| TW200727911A (en) | 2007-08-01 |
| ES2445035T3 (es) | 2014-02-27 |
| Publication | Publication Date | Title |
|---|---|---|
| DK1890684T3 (da) | Behandling af søvn/vågenhedsforstyrrelser | |
| DK1720866T3 (da) | Fremgangsmåde | |
| EP1845849A4 (en) | EXISCELET FOR THE LEGS | |
| EP1874239A4 (en) | HALF-POWERED EXOSCELETT OF LOWER EXTREMITY | |
| DK3403657T3 (da) | Anvendelse af oligouronater til behandling af slimhyperviskositet | |
| DK1938528T3 (da) | Provision af qos-behandling baseret på flere anmodninger | |
| DK1874781T3 (da) | Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme | |
| DK1986633T3 (da) | Behandling af duchennes muskeldystrofi | |
| DK1685834T3 (da) | Anvendelse af pinolensyre til behandling af obesitet | |
| DK2056807T3 (da) | Behandling af inflammatoriske sygdomme | |
| DK1869025T3 (da) | Piperazin-substituerede benzothiophener til behandling af mentale lidelser | |
| DK2084151T3 (da) | Substituerede dihydropyrazoloner til behandling af kardiovaskulære og hæmatologiske sygdomme | |
| NO20070251A (no) | Brønnbehandling | |
| DK1948176T3 (da) | Diarylurinstoffer til behandling af pulmonær hypertension | |
| FI20060708L (fi) | Hierontalaite | |
| NO20070297A (no) | Brønnbehandling | |
| CY2200156T2 (el) | Επεξεργασια λυματων | |
| DK1708992T3 (da) | Sulfonamidderivater til behandling af sygdomme | |
| DK1962869T3 (da) | Behandling af luftvejssygdomme | |
| DK1907374T3 (da) | Til behandling af gastrointestinale sygdomme anvendelige benzylpiperazin-derivater | |
| DK2056858T3 (da) | Behandling af lungesygdomstilstande | |
| DK1841433T3 (da) | Præparat til behandling af lidelser i centralnervesystemet | |
| BRPI0715728A8 (pt) | tratamento de distúrbios cartilaginosos | |
| DK2117565T3 (da) | Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme | |
| EP1937192A4 (en) | orthosis |